Related references
Note: Only part of the references are listed.SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
Alison Tarke et al.
CELL (2022)
Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice
Vidya Mangala Prasad et al.
CELL (2022)
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
Sam Afkhami et al.
CELL (2022)
Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England
Samantha J. Westrop et al.
JOURNAL OF INFECTION (2022)
Omicron: Call for updated vaccines
Xingguang Li
JOURNAL OF MEDICAL VIROLOGY (2022)
Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein
Suresh Kumar et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant
Dandan Tian et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
Lulu Bravo et al.
LANCET (2022)
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao et al.
NATURE (2022)
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Jonas S. Heitmann et al.
NATURE (2022)
Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors
Daichao Wu et al.
NATURE COMMUNICATIONS (2022)
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro M. Hirabara et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Intranasal COVID-19 vaccines: From bench to bed
Aqu Alu et al.
EBIOMEDICINE (2022)
Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel et al.
SCIENCE IMMUNOLOGY (2022)
Circular RNA vaccines against SARS-CoV-2 and emerging variants
Liang Qu et al.
CELL (2022)
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
Kun Xu et al.
CELL (2022)
T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine
Yongzheng Li et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model
Stephanie N. Langel et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants
Yin-Feng Kang et al.
NATURE COMMUNICATIONS (2022)
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Fengcai Zhu et al.
LANCET RESPIRATORY MEDICINE (2022)
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
Paul M. McKeigue et al.
LANCET RESPIRATORY MEDICINE (2022)
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2
Junyu Chen et al.
SCIENCE BULLETIN (2022)
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Alexander A. Cohen et al.
SCIENCE (2022)
Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern
Christopher L. D. McMillan et al.
VACCINE (2022)
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial
Jing-Xin Li et al.
LANCET RESPIRATORY MEDICINE (2022)
Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2
Hong-Su Park et al.
NPJ VACCINES (2022)
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex
Martina Patone et al.
CIRCULATION (2022)
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern
Mijia Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
Punnee Pitisuttithum et al.
ECLINICALMEDICINE (2022)
Safety and immunogenicity of Nanocovax, a SARS- CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
Thuy P. Nguyen et al.
LANCET REGIONAL HEALTH-WESTERN PACIFIC (2022)
Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals
Zi-Wei Ye et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Mucosal vaccines - fortifying the frontiers
Ed C. Lavelle et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
Wan Ni Chia et al.
LANCET MICROBE (2021)
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
T Cell Memory: Understanding COVID-19
Nicholas N. Jarjour et al.
IMMUNITY (2021)
Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern
Chia-En Lien et al.
CLINICAL INFECTIOUS DISEASES (2021)
Distribution and evolution of H1N1 influenza A viruses with adamantanes-resistant mutations worldwide from 1918 to 2019
Weijun He et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Structural insights into SARS-CoV-2 proteins
Rimanshee Arya et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice
Juan Garcia-Arriaza et al.
JOURNAL OF VIROLOGY (2021)
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
Lorena Sanchez-Felipe et al.
NATURE (2021)
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
J. Sadoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tissue-resident CD4+ T helper cells assist the development of protective respiratory B and CD8+ T cell memory responses
Young Min Son et al.
SCIENCE IMMUNOLOGY (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
Nanda Kishore Routhu et al.
IMMUNITY (2021)
Cryo-electron Microscopy Structure of S-Trimer, a Subunit Vaccine Candidate for COVID-19
Jiahao Ma et al.
JOURNAL OF VIROLOGY (2021)
Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week
Paloma Troyano-Hernaez et al.
VIRUSES-BASEL (2021)
T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine
Anna Schmidt et al.
VIRUSES-BASEL (2021)
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Joshua G. Liang et al.
NATURE COMMUNICATIONS (2021)
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
Qian He et al.
EMERGING MICROBES & INFECTIONS (2021)
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Dennis Lapuente et al.
NATURE COMMUNICATIONS (2021)
Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative review
Ronald Derking et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2021)
Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2
Huibi Cao et al.
CELL AND BIOSCIENCE (2021)
The basis of a more contagious 501Y.V1 variant of SARS-CoV-2
Haolin Liu et al.
CELL RESEARCH (2021)
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
Gregory Milne et al.
LANCET RESPIRATORY MEDICINE (2021)
Current and future nanoparticle vaccines for COVID-19
Mai N. Vu et al.
EBIOMEDICINE (2021)
BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype
Gisella Guerrera et al.
SCIENCE IMMUNOLOGY (2021)
Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-Like Nano-Particle
Joshua M. Royal et al.
VACCINES (2021)
Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Ezgi Hacisuleyman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Protein-based antigen presentation platforms for nanoparticle vaccines
Brian Nguyen et al.
NPJ VACCINES (2021)
Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2
Ang Gao et al.
ISCIENCE (2021)
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses
Anusha Nathan et al.
CELL (2021)
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Alexandra C. Walls et al.
CELL (2021)
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono et al.
CELL HOST & MICROBE (2021)
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
Yunlong Cao et al.
CELL RESEARCH (2021)
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
Shiyu Sun et al.
CELL RESEARCH (2021)
Neutralizing antibodies for the prevention and treatment of COVID-19
Lanying Du et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
Vivek P. Chavda et al.
DRUG DISCOVERY TODAY (2021)
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial
Nawal Al Kaabi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
Shipo Wu et al.
LANCET INFECTIOUS DISEASES (2021)
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Dami A. Collier et al.
NATURE (2021)
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
Paul T. Heath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Moriah Bergwerk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
VIEWPOINT: COVID-19 Scent of a vaccine
Frances E. Lund et al.
SCIENCE (2021)
A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters
Yangtao Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding
Jakob Trimpert et al.
CELL REPORTS (2021)
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection
Qibin Geng et al.
PLOS PATHOGENS (2021)
Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection
Jinkai Zang et al.
CELL DISCOVERY (2021)
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
Xingyue An et al.
ISCIENCE (2021)
T cell immunity to SARS-CoV-2
Julia Niessl et al.
SEMINARS IN IMMUNOLOGY (2021)
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
Szu-Min Hsieh et al.
ECLINICALMEDICINE (2021)
Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial
Yuyi Liao et al.
EMERGING MICROBES & INFECTIONS (2021)
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Alexander A. Cohen et al.
SCIENCE (2021)
Viral targets for vaccines against COVID-19
Lianpan Dai et al.
NATURE REVIEWS IMMUNOLOGY (2021)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
COVID-19: a new challenge for human beings
Penghui Yang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2
Cassandra L. Atzrodt et al.
FEBS JOURNAL (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
Qingqing Lin et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses
Victoria Matyushenko et al.
ANTIVIRAL RESEARCH (2020)
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Hui Wang et al.
CELL (2020)
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai et al.
CELL (2020)
Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
George Ueda et al.
ELIFE (2020)
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar et al.
SCIENCE IMMUNOLOGY (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Molecular Architecture of the SARS-CoV-2 Virus
Hangping Yao et al.
CELL (2020)
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Ahmed O. Hassan et al.
CELL (2020)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli et al.
CELL (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh et al.
SCIENCE (2020)
Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
Daning Wang et al.
NATURE COMMUNICATIONS (2020)
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes
Asaf Poran et al.
GENOME MEDICINE (2020)
Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo
Yu Kato et al.
IMMUNITY (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Structures and distributions of SARS-CoV-2 spike proteins on intact virions
Zunlong Ke et al.
NATURE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Sandhya Bangaru et al.
SCIENCE (2020)
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Xiancai Ma et al.
IMMUNITY (2020)
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Yixuan J. Hou et al.
SCIENCE (2020)
COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response
Swati Jain et al.
VACCINES (2020)
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Structure-Based Vaccine Antigen Design
Barney S. Graham et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Self-Assembling Nanoparticles Usher in a New Era of Vaccine Design
Rino Rappuoli et al.
CELL (2019)
A proof of concept for structure-based vaccine design targeting RSV in humans
Michelle C. Crank et al.
SCIENCE (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice
Xiaodan Cai et al.
ANTIVIRAL RESEARCH (2018)
Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines
Felix A. Rey et al.
CELL (2018)
Bionanotechnology for vaccine design
Steven Frey et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
Vaccine-preventable disease control in the People's Republic of China: 1949-2016
Wenzhou Yu et al.
VACCINE (2018)
Stalking new vaccines: Methods that target the stems of viral proteins could put universal vaccines within reach
Carrie Arnold
NATURE MEDICINE (2017)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
From empiricism to rational design: a personal perspective of the evolution of vaccine development
Ennio De Gregorio et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread
Lu Lu et al.
MICROBES AND INFECTION (2013)
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus
J Stevens et al.
SCIENCE (2004)